Overall rank by patents
#24,245
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 10 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS).
The verdict
Ems-chemie holds 11 US patents across 10 technology areas, rank #24,245 of 50,000 tracked assignees.
Ems-chemie Ag has been granted 11 US utility patents between 2015 and 2025, placing Ems-chemie Ag at rank #24,245 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in C08L (COMPOSITIONS OF MACROMOLECULAR COMPOUNDS). As a Foreign Corporation, Ems-chemie Ag is one of the more focused assignees in the PatentsView dataset. By volume, Ems-chemie sits between Election Systems & Software, Llc (11 patents, rank #24,241) and EOS Of North America, Inc. (11 patents, rank #24,249) - the closest US assignees by grant volume. The composite Innovation Score of 51.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 2 in the 2015–2019 window, a +350% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ems-chemie Ag's 20.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ems-chemie Ag against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ELECTION SYSTEMS & SOFTWARE, LLC
11 patents
ELM
11 patents
ELYSIS LIMITED PARTNERSHIP
11 patents
EMAGE VISION PTE. LTD.
11 patents
ENERGYBOX LTD.
11 patents
ENIG ASSOCIATES, INC.
11 patents
ENVIROSIGHT LLC
11 patents
EOS of North America, Inc.
11 patents
EMS-CHEMIE AG
11 patents
What this shows Ems-chemie holds 11 patents at rank #24,245, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Ems-chemie's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 9.1% |
| 2017 | 1 | 9.1% |
| 2024 | 5 | 45.5% |
| 2025 | 4 | 36.4% |
Top 10 of 10 technology areas
Overall rank by patents
#24,245
Across all tracked assignees
51.8 out of 100
How to use this portfolio
Ems-chemie's 11 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.